ICYMI: Targeting RNA splicing as an alternative strategy in chronic lymphocytic leukemia? @prajishiyer.bsky.social & team find mutation in the RNA splicing factor SF3B1 activates the mTOR pathway to contribute to aggressive CLL: buff.ly/qkFAW4B

Proud of you, Prajish!

Thank you @iwCLL2025 for the opportunity to present in Poland @wanglabcityofhope.bsky.social @ericalytical.bsky.social

Targeting RNA splicing as an alternative strategy in chronic lymphocytic leukemia? @prajishiyer.bsky.social & team find mutation in the RNA splicing factor SF3B1 activates the mTOR pathway to contribute to aggressive CLL: buff.ly/qkFAW4B

Congratulations to my graduate student, Erica Niewold @ericalytical.bsky.social, for being selected by @ash.hematology.org to receive the ASH Graduate Hematology Award (AGHA)! #ASHAwards

Very proud of my trainee Prajish @prajishiyer.bsky.social receiving Career Development Grant from Tower Cancer Research Foundation! Congratulations, Prajish!

Thank you Tower Cancer research foundation for the early career investigator award. @wanglabcityofhope.bsky.social

Thank you #ASH2024 for the opportunity to share our research on Richters transformation @ash-hematology.bsky.social @wanglabcityofhope.bsky.social